Selinexor in combination with R-CHOP for frontline treatment of non-Hodgkin lymphoma: results of a phase 1 study

BACKGROUND: The nuclear exporter protein exportin-1 (XPO1) is overexpressed in non-Hodgkin’s lymphoma (NHL) and correlates with poor prognosis. We evaluated enhancing R-CHOP activity in NHL by targeted inhibition of XPO1 using the Selective Inhibitor of Nuclear Export (SINE) compounds, selinexor and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Seymour, Erlene K., Yar Khan, Husain, li, Yiwei, Chaker, Mahmoud, Muqbil, Irfana, Aboukameel, Amro, Ramchandren, Radhakrishanan, Houde, Christiane, Sterbis, Golbon, Yang, Jay, Bhutani, Divaya, Pregja, Silvana, Reichel, Kathy, Huddlestun, Amy, Neveux, Colleen, Corona, Kelly, Landsman, Yosef, Shah, Jatin, Kauffman, Michael, Shacham, Sharon, Mohammad, Ramzi M., Azmi, Asfar S., Zonder, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8197746/
https://ncbi.nlm.nih.gov/pubmed/33785483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-4929
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados